GIMOTI FDA approval date

The FDA approved GIMOTI on 19 Jun 2020.

FDA approval date
19 Jun 2020

Drug identity has not yet been verified against registry records

Also recorded as METOCLOPRAMIDE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-06-19DayGIMOTIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209388", "applicant_as_listed_by_fda": "QOL MEDCL", "brand_names": ["GIMOTI"], "active_ingredients": ["METOCLOPRAMIDE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200619", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026